Purpose: To identify and determine differences in lipid profile of aqueous humour (AH) in patients with Fuchs endothelial corneal dystrophy (FECD). Methods: Lipidomic profile of eight AH samples of FECD patients and 10 control samples was analysed. Patients with previous history of anterior segment surgery, anterior segment pathology or intraocular injections were excluded. Topical ocular medications within the last 6 months were reported. Aqueous humour (AH) was obtained during the first step of Descemet membrane endothelial keratoplasty in FECD patients and during refractive lensectomy in the control group. Lipidomic ultra-performance liquid chromatography mass spectrometry was used to perform an optimal profiling of glycerolipids, sterol lipids, sphingolipids and glycerophospholipids. Metabolite extraction was accomplished by fractionating the samples into pools of species with similar physicochemical properties. Results: The levels of 27 of 110 lipids change significantly in the AH of FECD eyes when compared to control samples. The concentration of most diacylglycerophosphocholines and 1-ether, 2-acylglycerophosphocholines increases in the AH of FECD eyes when compared to healthy controls. In addition, eight sphingomyelins and up to two long-chain highly unsaturated cholesteryl esters present higher levels in FECD samples when compared to controls. Conclusion: The lipid composition of AH in FECD patients differs from that of healthy subjects. Those changes may reflect oxidative stress-related changes in the lipid metabolism of the corneal endothelial cells in FECD.
Introduction
Fuchs endothelial corneal dystrophy (FECD) is a degenerative corneal condition characterized by deposits of collagen in the Descemet membrane (DM), subsequent changes in cell morphology, apoptosis (Borderie et al. 2000; Jurkunas et al. 2010; Czarny et al. 2013 ) and endothelial cell loss. The characteristic clinical features typically appear between the 5th and 6th decades of life and vary from macroscopic guttae producing light scattering and decrease in visual quality, to chronic, full thickness corneal oedema (Zhang & Patel 2015) . Currently, the disease is considered to be a multifactorial condition, in which genetic (Biswas et al. 2001; Gottsch et al. 2005) and environmental factors, such as UV light-induced oxidative stress (Karamichos et al. 2014 ), contribute to its onset.
Recent studies point to the endothelial cell metabolism as a key to understand the physiopathology of the disease. Findings report an increase in intracellular unfolded protein response (UPR) (Engler et al. 2010 , Wojcik et al. 2013 , expression of oxidative stress markers (Jurkunas et al. 2010) , DNA fragmentation (Szentm ary et al. 2005) and subsequent cell apoptosis (Li et al. 2001) in FECD. Conversely, oxidative stress can cause FECD-like morphological changes in vitro (Jurkunas et al. 2010) . This bidirectional relation between oxidative stress and altered cell metabolism constitutes a crucial key in the physiological background of FECD. However, the metabolical link between aetiology and the long time known macroscopic (Fuchs 1910 ) and morphologic changes of corneal endothelium remains poorly understood.
Lipid pathways modulate the apoptotic response in inflammation and oxidative stress (Kunchithapautham et al. 2014; Turkdogan et al. 2014 ). In addition, apoptosis alters lipid synthesis in systemic (van Diepen et al. 2013) and ocular conditions, such as glaucoma (Burgess et al. 2015) . Consequently, changes in cell lipid synthesis could be expected in the endothelial cell metabolism in FECD, where, as in glaucoma, DNA damage and increased oxidative stress chronically coexist (Wojcik et al. 2013; Kim et al. 2014) .
Lipidomic research has been greatly facilitated by recent technical advances such as ultra-performance liquid chromatography mass spectrometry (Nygren et al. 2011) . Ultra-performance liquid chromatography mass spectrometry enables reliable lipid identification and data analysis for qualitative and quantitative assessment of multiple lipid species (Barr et al. 2012) .
This study presents distinctive lipidomic differences of aqueous humour (AH) in patients with FECD compared with controls, mainly in sphingomyelins (SM) and glycerophosphocholines.
Materials and Methods

Demographic and clinical data
Lipidomic profile of 18 AH samples, 10 controls and eight FECD were analysed. Patients with any signs of lens sclerosis or incipient cataract at slitlamp examination or a previous history of anterior segment surgery or chronic pathology were excluded from the study. In the FECD group, any topical ocular medications within the last 6 months before the taking of samples were reported. Controls did not receive any topical ocular medication during the last 6 months before surgery. In all FECD patients, YAG iridotomy was performed 3 weeks before surgery followed by topical fluormetholone 39 day during 3-5 days. None of the patients received ocular topical medication during the last 2 weeks prior to sample extraction.
Subjects were divided into two groups according to their diagnosis. Diagnosis of FECD was made through clinical slit-lamp examination, specular microscopy and corneal pachymetry. Clinical severity has been graded at the slit lamp by assessing the confluence and area of guttae and the presence of posterior or full thickness corneal oedema (Louttit et al. 2012) . All the patients presented a FECD stage II with confluent guttae and minimal-tomild posterior oedema (Adamis et al. 1993) . Controls underwent elective, refractive lensectomy.
Average age was 50.8 and 56.8 years in the control and FECD groups, respectively. Preoperative Snellen bestcorrected visual acuity was 0.9 and 0.15, in the control and FECD groups, respectively. One patient in the FECD group was pseudophakic and nine phakic.
The study was approved by the regulatory authority, Comite Etico de Investigaci on Cl ınica de Euskadi (CEIC-E). All patients signed an informed consent prior to their enrolment. The research reported in this study adhered to the tenets of the Declaration of Helsinki.
Aqueous humour sampling and storage
Aqueous humour was obtained during the first step of a surgical procedure, refractive lensectomy in controls and Descemet membrane endothelial keratoplasty in FECD patients. After topical 1% povidone-iodine instillation, we aspirated around 150 ll of AH through a corneal side-port using a 27-gauge blunt cannula. No adverse event occurred during the sampling procedure other than a light shallow of the anterior chamber. Aqueous humour was transferred to a 0.5-ml tube (Eppendorf AG, Hamburg, Germany) after aspiration and stored at À80°C at the tissue bank for up to 9 months (range: 1-9). Prior to the analyses, samples were left at 24°C for 3 hr to gradually adjust to room temperature. Control samples were obtained at Begitek Cl ınica Oftalmol ogica (Donostia, Guip uzcoa, Spain). Fuchs endothelial corneal dystrophy (FECD) samples were obtained at the Netherlands Institute of Innovative Ocular Surgery (Rotterdam, The Netherlands). The metabolomic analyses were performed by OWL Metabolomics (Derio, Spain).
Metabolite extraction
The extraction solvent was spiked with metabolites not detected in unspiked human AH extracts. After vortex mixing, the samples were incubated for 1 hr at À20°C. After centrifugation at 16 000 g for 15 min, the organic dry phase was collected, reconstituted in acetronitrile/isopropanol (1:1), centrifuged (16 000 g for 5 min) and transferred to vials for UHPLC-ToF-MS analysis. Additionally, a pooled sample was included in the analysis and considered as quality control (QC) sample (Fig. 1) .
The metabolite classification used in this study follows the classification system proposed by the International Lipid Classification and Nomenclature Committee (ILCNC) (Fahy et al. 2008 ).
UHPLC-ToF-MS analysis
Chromatography was performed on a 1-mm i.d. 9 100-mm ACQUITY 1.7-lm C8 BEH column (Waters Corp., Milford, CT, USA) using an ACQUITY UPLC system (Waters Corp.).
Data preprocessing
Data preprocessing (MASSLYNX 4.1 software; Waters Corp.) generated a list of chromatographic peak areas for the metabolites detected in each sample injection. A normalization procedure was applied after data correction with QC, internal standards and trend amendment by dividing every metabolite species relative concentration by its corresponding 'total ion' parameter. A limit of detection (LOD) was established as three times the background noise level. Metabolites with more than five sample values under the LOD were excluded from the analysis.
Statistical data analysis
Principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA) were applied in the multivariate analysis (MVA). All the 
Results
Multivariate analysis
The obtained PCA (Jolliffe 2002 ) scores plot showed clear clustering between FECD and control samples in the first component (t1), explaining 26.3% of the variation of the data (Fig. 2) . The PCA showed no outliers. Cumulative R 2 = 0.29 indicates that the PCA model had notable degree of fit and predictive ability for the studied sample.
Lipids responsible for the patterns seen among the groups of samples can be observed in the lower chart (Fig. 3) . The highest differences were due to the elevated levels of SM and cholesteryl esters (ChoE) in FECD samples when compared to controls. The supervised analysis (PLS-DA) sample distribution dovetailed with the unsupervised PCA findings.
Univariate analysis
The concentration of 27 of 110 lipids were significantly changed (p < 0.05) in The plot combines statistical significance (y-axis) with the magnitude of the changefold change (x-axis). The higher a lipid specie is represented in the diagram, the closer it is to statistically significant levels. Complementarily, the more peripheral a lipid is represented in the diagram, the greater is the concentration fold change compared to controls.
FECD samples when compared to controls (Fig. 4) . The majority of these species (15) belonged to the chemical groups of diacylglycerophosphocholines and 1-ether, 2-acylglycerophosphocholines (MEMAPC), while SM and ChoE also present various significant lipid species altered in FECD (Table 1) . Diacylglycerophosphocholines and MEMAPC were the groups of lipids with more species showing statistically significant differences. The greatest increase was observed in PC (16:1/ 18:2), which was 3.94-fold higher in FECD.
Up to eight SM increased significantly in FECD, reaching SM (39:1) an increase of 2.25-fold when compared to healthy samples.
Up to two long-chain highly unsaturated ChoE, ChoE (20:3) and ChoE (18:2), presented higher concentration in FECD. In addition, unesterified cholesterol increased more than 1.92-fold in FECD samples when compared to controls (Fig. 5) .
Regarding enzyme activity, there was an increase of 30% in the ratio SM+DG/Cer+PC, which may reflect increased synthesis of SM and diacylglycerols (DAG) from ceramides (Cer) and PC by the enzyme sphingomyelin synthase (SMS).
Discussion
This study has unravelled elevated SM and ChoE levels in FECD reflecting the rise in the synthesis of SM and DAG. Our findings converge with previously reported AH proteomic changes (Richardson et al. 2010) , suggesting an alteration in lipid and protein synthesis, which could represent an additional strand pathophysiology of FECD.
The bidirectional relation between lipids and cellular changes found in FECD has been widely reported in the literature. Cholesteryl esters and cholesterol, overexpressed in FECD, have shown cytoprotectant properties of potential clinical relevance (Zager & Kalhorn 2000) . Correlating to those findings, overexpression of cholesterol acyltransferase and subsequent increase in ChoE have been reported under oxidative stress (Kim et al. 2011) .
Adding evidence presents the UPR to intracellular oxidative stress as responsible for the changes in SM and ChoE in FECD. Major lipid perturbations have been found alongside UPR signalling activation, resulting in dysfunctional lipid synthesis (Basseri & Austin 2012) . Protein folding, secondary to insufficient UPR, results in generation of reactive oxygen species (Gregersen & Bross 2010) , increasing intracellular oxidative stress and establishing a positive feedback by changing the redox state in the endoplasmic reticulum (Li et al. 2010) . Oxidative stress-related morphological changes in ER (Chiang et al. 2005 ) suggest a bidirectional cause-effect scenario in the aetiology of FECD and emphasize the key role of UPR in the pathogenesis of the condition (Fig. 6) .
Due to the lack of previous scientific literature in lipidomic changes and FECD, our study was designed with an exploratory scope, aiming to screen for potential changes in a wide range of lipids that may support future, more specific works. The lack of correction for multiplicity allows us to present all the potential relevant information, but entails a potential bias, by increasing type I error. The reader should be aware of this, especially when regarding statistical differences with p-values at the low end of the table.
Despite topical treatment monitoring, stringent inclusion criteria and standardized sampling conditions, some limitations of the AH have to be discussed. Aqueous humour enables safe, in vivo, sample collection, ruling out post-mortem metabolical changes. However, AH is an indirect marker of cellular changes in the anterior chamber, and therefore, results should be interpreted with caution and correlated with other works in ex vivo corneal samples (Priyadarsini et al. 2015) .
Lens capsule permeability or changes in AH production may have to be considered in relation to our data. Lens anterior permeability is reported to be restricted to small and mid-size molecules, with a cut-off molecular weight of 166 AE 82 kDa (Kastner et al. 2013 ), three to six folds smaller than lipid species studied in this work (SM around 350 kDa, PC around 800 kDa).
Controls, who underwent a refractive lensectomy, were myopic, showing statistically significant differences in axial length compared with FECD patients. Levels of vascular endothelial growth factor (Shin et al. 2012 ) and matrix metalloproteinase 2 (Jia et al. 2014 ) increase in AH in highly myopic eyes. However, those changes may be associated with matrix metalloproteinase gene polymorphisms (Wojciechowski et al. 2010) and no evidence of lipid-related alterations in AH of myopic patients has been previously reported.
FECD patients received topical fluorometholone during 3-5 days, 3 weeks before surgery. Steroids are well-known regulators of water and sodium transport in epithelial tissue and can cause a clinically significant rise of intraocular pressure (Rauz et al. 2003) . Topical steroids reach peak concentrations after 2 hr and levels in the anterior chamber can be measured up to 24 hr after topical instillation (McGhee et al. 1990 ). In our study, we report a minimum of 2-week washout period after the last instillation which rules out drug-related AH changes.
Age distribution could arguably play a role in AH composition (Goel 2010) . However, MVA did not show agerelated differences in lipid levels. This dovetails with previously reported AH proteome analysis in FECD, where proteomic differences were independent of age distribution (Richardson et al. 2010) .
Although FECD and bullous keratopathy (BK) differ in their pathophysiology and therefore show a different onset, chronology and severity, they share some histological changes, especially in advanced stages where stromal oedema and fibrosis predominate. Future studies of AH lipidomics in BK may provide a useful insight into the biochemical characteristics of both conditions. In summary, our study demonstrates changes in the lipidomic profile of AH in FECD, mainly related to the increase in SM and ChoE levels and the potential upregulation of SMS activity. Our results point to the presence of intracellular lipid-related metabolic changes in the pathophysiology of the disease. Those changes may evolve in future biomarkers for disease severity and characterization, potentially enabling preclinical diagnosis and/or a more case-specific therapeutic approach. A better understanding of the biophysical parameters that modulate the endothelial morphological changes remains future challenges in FECD research.
